Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Syndrome × maltodextrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3 Colonic Neoplasms 3 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Diarrhea 2 Vaso-Occlusive Crises 1 Seaweed Associated Changes in Healthy Subjects 1 Sarcopenia 1 Rectal Neoplasms 1 Proctitis 1 Neoplasms 1 Multiple Myeloma 1 Mucositis 1 Metabolic Syndrome 1 Malnutrition 1 Lymphoma 1 Liver Failure 1 Insulin Resistance 1 Hyperandrogenism 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Fibrosis 1 Colonic Polyps 1 Cholangiocarcinoma 1 Chemotherapy-related Diarrhea 1 Carcinoma, Hepatocellular 1 Anovulation 1 Anemia, Sickle Cell 1

Interventions

Metformin 7 Pioglitazone 2 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 Blood Pressure 2 semaglutide 1 maltodextrin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1 Vascular Stiffness 1 Triptorelin Pamoate 1 Topiramate 1 Tirzepatide 1 Testosterone 1 Spironolactone 1 Qsymia 1 Pyruvic Acid 1 Pulse Wave Analysis 1 Phlebotomy 1 Phentermine 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Observation 1 Naltrexone 1 Medical History Taking 1 Liraglutide 1 Leuprolide 1 Human Growth Hormone 1 Hepatectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06852365 2026-02-19

COR-PCOS

University of Pennsylvania

Phase 2 Recruiting

Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡